Literature DB >> 20557672

Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity.

Fahri Sahin1, Cigir Biray Avci, Cumhur Gunduz, Canfeza Sezgin, Ilgin Yildirim Simsir, Guray Saydam.   

Abstract

In this study, we aimed to investigate the potential relationship between gossypol-induced cytotoxicity of human promyelocytic leukemia cell line (HL-60) leukemic cells and intracellular serine/threonine protein phosphatase (PP) dynamics and human telomerase reverse transcriptase (hTERT) activity. Gossypol was found to be cytotoxic in HL-60 cells with the IC(50) dose of 4.5 microM. The combination of gossypol and okadaic acid in IC(50) doses revealed the increased cytotoxicity in a time-dependent manner. Treatment of cells with gossypol has shown significant decrease in PP2A activity. The expression of the PP2A catalytic subunit was downregulated in gossypol-treated cells with 24 hours' intervals. hTERT mRNA levels were gradually decreased. In conclusion, during gossypol-induced cytotoxicity, intracellular activity and expression of PP2A was decreased as well as the activity of hTERT. The variation of hTERT activity in gossypol-treated HL-60 cells may be the potential reason for the phosphatase interaction during the gossypol treatment of leukemic cells resulting in cellular cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20557672     DOI: 10.1179/102453309X12583347113771

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  4 in total

1.  A critical role of nicotinamide phosphoribosyltransferase in human telomerase reverse transcriptase induction by resveratrol in aortic smooth muscle cells.

Authors:  Peixin Huang; Sean M Riordan; Daniel P Heruth; Dmitry N Grigoryev; Li Qin Zhang; Shui Qing Ye
Journal:  Oncotarget       Date:  2015-05-10

2.  Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2/Mcl-1 pathway.

Authors:  Ken Sadahira; Morihiko Sagawa; Tomonori Nakazato; Hideo Uchida; Yasuo Ikeda; Shinichiro Okamoto; Hideaki Nakajima; Masahiro Kizaki
Journal:  Int J Oncol       Date:  2014-09-15       Impact factor: 5.650

Review 3.  Broad targeting of resistance to apoptosis in cancer.

Authors:  Ramzi M Mohammad; Irfana Muqbil; Leroy Lowe; Clement Yedjou; Hsue-Yin Hsu; Liang-Tzung Lin; Markus David Siegelin; Carmela Fimognari; Nagi B Kumar; Q Ping Dou; Huanjie Yang; Abbas K Samadi; Gian Luigi Russo; Carmela Spagnuolo; Swapan K Ray; Mrinmay Chakrabarti; James D Morre; Helen M Coley; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; William G Helferich; Xujuan Yang; Chandra S Boosani; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; W Nicol Keith; Alan Bilsland; Dorota Halicka; Somaira Nowsheen; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2015-04-28       Impact factor: 15.707

4.  Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis.

Authors:  Eva Schruf; Victoria Schroeder; Christian A Kuttruff; Sabine Weigle; Martin Krell; Maryke Benz; Tom Bretschneider; Alexander Holweg; Michael Schuler; Manfred Frick; Paul Nicklin; James P Garnett; Mirko C Sobotta
Journal:  Respir Res       Date:  2019-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.